- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Pfizer Limited — Board Meeting, 09-02-2026: Outcome of Board Meeting
09-02-2026 | 07:29 pm
09-02-2026 | 07:29 pm
Pfizer's Board approved financial results for the quarter & nine months ended Dec 31, 2025. Q3 net profit grew to ₹141.84 Cr on ₹645.03 Cr revenue. The company signed a supply & marketing deal with Cipla for 4 brands, leading to ₹58.20 Cr in exceptional costs.
No comments yet. Be the first to comment!